Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14299876 | 0.92 | MAPK1 (0.33) | MAPK1 | |
| SCHEMBL13290098 | 0.91 | MAPK1 (0.51) | MAPK1LMNA | |
| SCHEMBL12723445 | 0.89 | MAPK1 (0.32) | MAPK1 | |
| SCHEMBL13871885 | 0.89 | MAPK1 (0.32) | MAPK1 | |
| SCHEMBL13889856 | 0.83 | — | — | |
| SCHEMBL13876987 | 0.81 | — | — | |
| SCHEMBL13148271 | 0.80 | MAPK1 (0.38) | MAPK1LMNA | |
| SCHEMBL310962 | 0.79 | MAPK1 (0.59) | MAPK1LMNA | |
| SCHEMBL11322550 | 0.77 | MAPK1 (0.34) | MAPK1 | |
| SCHEMBL11324452 | 0.76 | MAPK1 (0.33) | MAPK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461235-B2 | Use of polymer powder containing UV absorber for the stabilisation of polymers against the effects of UV radiation | BASF SE (DE) | 2013-06-11 | — | — | US | disclosed |
| US-8461235-B2 | Use of polymer powder containing UV absorber for the stabilisation of polymers against the effects of UV radiation | BASF SE (DE) | 2013-06-11 | — | — | US | disclosed |
| US-8277695-B2 | Reversibly thermochromic compositions | BASF SE (DE) | 2012-10-02 | — | — | US | disclosed |
| US-8262945-B2 | Stabilization of photochromic systems | BASF SE (DE) | 2012-09-11 | — | — | US | disclosed |
| US-8119778-B2 | Reversibly thermochromic compositions | BASF SE (DE) | 2012-02-21 | — | — | US | disclosed |
| US-20110180767-A1 | Reversibly thermochromic compositions | CIBA CORPORATION | 2011-07-28 | — | — | US | disclosed |
| US-20110092632-A1 | POROUS INORGANIC MATERIALS CONTAINING POLYMER ADDITIVES | BRAND FABIEN JEAN | 2011-04-21 | — | — | US | disclosed |
| US-7820744-B2 | Stabilizer mixtures | CIBA SPECIALTY CHEMICALS CORP. (US) | 2010-10-26 | — | — | US | disclosed |
| US-7786199-B2 | Flame-retardants | CIBA SPECIALTY CHEMICALS CORP. (US) | 2010-08-31 | — | — | US | disclosed |
| US-20100190929-A1 | USE OF POLYMER POWDER CONTAINING UV ABSORBER FOR THE STABILISATION OF POLYMERS AGAINST THE EFFECTS OF UV RADIATION | BASF AKTIENGESELLSCHAFT (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20090105379-A1 | Stabilizer mixtures | GUGUMUS FRANCOIS | 2009-04-23 | — | — | US | disclosed |
| US-20090093572-A1 | Stabilizer mixtures | GUGUMUS FRANCOIS | 2009-04-09 | — | — | US | disclosed |
| US-20080269383-A1 | Flame-Retardants | CIBA SPECIALTY CEMICALS HOLDING INC. (CH) | 2008-10-30 | — | — | US | disclosed |
| US-20080220031-A1 | Dermocosmetic Preparations | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-11 | — | — | US | disclosed |
| US-20080220031-A1 | Dermocosmetic Preparations | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-11 | — | — | US | disclosed |
| US-20080058459-A1 | Porous Inorganic Materials Containing Polymer Additives | CIBA CORP. | 2008-03-06 | — | — | US | disclosed |
| US-20080027160-A1 | Weatherability of flame retardant polyolefin | ZINGG JURG | 2008-01-31 | — | — | US | disclosed |
| US-20070135537-A1 | Agricultural articles | BONORA MICHAEL | 2007-06-14 | — | — | US | disclosed |
| US-20070064195-A1 | Stabilization of photochromic systems | CIBA CORPORATION | 2007-03-22 | — | — | US | disclosed |
| US-7169835-B2 | Stabilizer mixture | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110180767-A1 | Reversibly thermochromic compositions | C1R, C3AR1, C9 | MAPK1 1896/4885LMNA 2222/4885 |
| US-20080220031-A1 | Dermocosmetic Preparations | C3AR1, C1S, C1R | MAPK1 2373/4885LMNA 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.